Variables | Neoadjuvant Chemotherapy [n - 16] | Primary Cytoreductive surgery [n- 28] | P value |
1. Estimated blood loss, mean (SD), ml | 946.9 (747.1) | 790 (611.9) | 0.477 |
2. Intraoperative complications |
Blood loss > 2000 ml | 3(18.8%) | 2(07.1%) | 0.243 |
Visceral injury (Urinary tract) | 1(06.3%) | 1(03.5%) |
Visceral injury (Bowel) | 0 | 1(03.5%) |
3. Duration of hospital stay (mean), days | 5.63 | 5.61 | 0.977 |
4. Intraoperative complications |
Urosepsis | 1(06.3%) | 0 | |
AKI | 1(06.3%) | 0 | |
Readmission | 0 | 0 | |
Mortality | 0 | 0 | |
5. Debulking status |
Suboptimal (> 1 cm) | 5(31.2%) | 11(39.3%) | 0.547 |
Optimal (=> | 3(18.8%) | 2(07.1%) |
No gross residual | 8(50.0%) | 15(53.6%) |